Novartis Lifts FY23 View As Q2 Results Top Market, Initiates $15 Bln Buyback; Stock Up

Shares of Novartis AG were gaining around 4 percent in the morning trading in Switzerland as well as in pre-market activity on the NYSE after the drug major raised its fiscal 2023 outlook on Tuesday after reporting higher second-quarter results.

Related Keywords

Switzerland ,United States ,Swiss ,American , ,Novartis ,Thomson Reuters ,Swiss Exchange ,Extraordinary General Meeting ,American Depositary Receipt ,Sandoz ,Share Buyback ,Pin Off ,Drug Major ,Market Estimates ,Ovartis Earnings ,Vas Narasimhan ,